Merck
MRK
#58
Rank
C$398.12 B
Marketcap
C$161.20
Share price
0.23%
Change (1 day)
45.51%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): C$4.87

According to Merck's latest financial reports the company's current EPS (TTM) is C$4.98. In 2025 the company made an earnings per share (EPS) of C$10.20 an increase over its 2024 EPS that were of C$9.46.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$4.87-52.22%
2025C$10.207.81%
2024C$9.464308.46%
2023C$0.21-97.32%
2022C$8.0210.92%
2021C$7.2384.68%
2020C$3.92-27.2%
2019C$5.3863.44%
2018C$3.29151.11%
2017C$1.31-54.58%
2016C$2.8830.21%
2015C$2.22-61.99%
2014C$5.83180.51%
2013C$2.08-31.82%
2012C$3.056.62%
2011C$2.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.23 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.83 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.83-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.05 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.51 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.27 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$3.58-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$4.98 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.44 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$1.92-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel